Stada Arzneimittel AG’s recent acquisition spree is continuing as the German firm’s private-equity backers seek to bolster its footprint in the growth markets of Eastern Europe.
The company said it was poised to become a major player in Ukraine through the acquisition of Biopharma’s pharmaceutical prescription and consumer health businesses